‘There is an overweight of cardiovascular deaths in the Pfizer group’ which is ‘a potential danger signal that warrants further scrutinization,’ the study’s lead author Professor Christine Stabell-Benn said.
‘There is an overweight of cardiovascular deaths in the Pfizer group’ which is ‘a potential danger signal that warrants further scrutinization,’ the study’s lead author Professor Christine Stabell-Benn said.